ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 195327 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 195327; 2) Community: the network communities that were significantly associated with the response to NSC 195327; 3) Molecule: the relationships between components within communities and NSC 195327; 4) MDR: the compounds that were significantly associated with the NSC 195327.

NSC Compound Enrichment Correlation
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0238174255956147 0.31394453
NSC 105132 Deoxycamptothecin 0.024108502230778 0.38552253
NSC 107043 Null 0.024108502230778 0.23372388
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.024108502230778 0.28935653
NSC 135073 WITHACNISTIN 0.024108502230778 0.43258681
NSC 261726 ICN 4221 0.0241085022307781 0.18147658
NSC 295499 Camptothecin Derivative 0.0241085022307781 0.43373772
NSC 354051 LISCUNDITRIN 0.0241085022307781 0.18157974
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.0241085022307781 0.3659164
NSC 603084 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- 0.0241085022307781 0.52503524
Total:83  Current:42    [First] [Prev] [Next] [Last]